Editors-in-Chief

Editorial Board

Jean-Pierre Abastado

Singapore, SG

Matthew Albert

Paris, FR

James P. Allison

New York, NY, US

Ana C. Anderson

Harvard University
Cambridge, MA USA

Ron N. Apte

Ben-Gurion University of the Negev
Beer-Sheva, IL

Maha Ayyoub

INSERM
Nantes, FR

Jean-François Bach

Académie des sciences
Paris, FR

Philipp Beckhove

German Cancer Research Center
Heidelberg, DE

Thomas Blankenstein

Max-Delbrück-Centrum
Berlin, DE

Jean-Yves Blay

Lyon, FR

Marc Bonneville

INSERM U892
Nantes, FR

Lisa H. Butterfield

Hillman Cancer Center
Pittsburgh, PA, USA

Anne Caignard

Paris, FR

Xuetao Cao

Chinese Academy of Medical Sciences
Beijing, CN

Chiara Castelli

Istituto Nazionale Tumori
Milano, IT

Federica Cavallo

University of Torino
Torino, IT

Vincenzo Cerundolo

University of Oxford
Oxford, UK

Lieping Chen

New Haven, CT, US

Yao-Tseng Chen

Cornell University
New York, NY USA

Aled Clayton

Cardiff, UK

Mario Colombo

Istituto Nazionale Tumori
Milano, IT

Marco Colonna

Washington University School of Medicine
St. Louis, MO, USA

George Coukos

Philadelphia, PA, US

Pierre Coulie

Louvain, BE

Madhav Dhodapkar

The Rockefeller University
New York, NY, USA

Chen Dong

Houston, TX, US

Glenn Dranoff

Boston, MA, US

Alexander Eggermont

Villejuif, FR

Dean Felsher

Stanford University
Stanford, CA, US

Carl G. Figdor

Nijmegen Centre for Molecular Life Sciences
Nijmegan, NL

Olivera J. Finn

Pittsburgh, PA, US
Web site

Guido Forni

Molecular Biotechnology Center
Torino, IT

Bernard A. Fox

Portland, OR, US

Wolf-Hervé Fridman

Paris, FR

Dmitry I. Gabrilovich

Tampa, FL, US

Thomas F. Gajewski

University of Chicago
Chicago, IL, US

Ellie Gilboa

University of Miami
Miami, FL, US

Sacha Gnjatic

Ludwig Institute for Cancer Research at Memorial Sloan-Kettering Cancer Center
New York, NY, USA

F. Stephen Hodi

Dana-Farber Cancer Institute
Boston, MA, USA

Axel Hoos

Glaxo Smith Kline
Collegeville, PA, USA

Anne Hosmalin

Paris-Descartes University
Paris, FR

Dirk Jaeger

National Center for Tumor Diseases
Heidelberg, DE

Elizabeth M. Jaffee

Baltimore, MD, US

Elke Jäger

Krankenhaus Nordwest
Frankfurt, DE

Pawel Kalinski

Pittsburgh, PA, US

Klas Kärre

Karolinska Institute
Stockholm, SE

Rolf Kiessling

Stockholm, SE

John Kirkwood

University of Pittsburgh School of Medicine
Pittsburgh, PA

Eva Klein

Stockholm, SE

George Klein

Karolinska Institute
Stockholm, SE

Alexander Knuth

University Hospital Zürich
Zürich, CH

Peter H. Krammer

German Cancer Research Center
Heidelberg, Germany

Oliver Lantz

Curie Institute
Paris, FR

Claire Lewis

University of Sheffield
Sheffield, UK

Roland Liblau

INSERM UMR1043-CNRS UMR5282-Université Toulouse III
Toulouse, FR

Michael T. Lotze

Pittsburgh, PA, US

Enrico Lugli

Humanitas Clinical and Research Center
Rozzano, IT

Jean-Pierre Mach

University of Lausanne
Epalinges, CH

Francesco Marincola

Trans-NIH Center for Human Immunology
Bethesda, MD, US

Carlos Martinez-A

Ministry for Science and Innovation
Madrid, ES

Ignacio Melero

Pamplona, ES

Cornelis J. Melief

University Hospital Leiden
Leiden, NL

Ira Mellman

Genentech Inc.
South San Francisco, CA, US

Lorenzo Moretta

Genova, IT

Sergei A. Nedospasov

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Moscow, RU

Kunle Odunsi

Roswell Park Cancer Institute
Buffalo NY USA

Hideho Okada

University of Pittsburgh School of Medicine
Pittsburgh, PA, USA

Anna Karolina Palucka

Baylor University Medical Center
Dallas, TX, US

Giorgio Parmiani

Milan, IT

Marcus E. Peter

Northwestern University Feinberg School of Medicine
Chicago, IL USA

Angel Porgador

Beer-Sheva, IL

George Prendergast

Wynnewood, PA, US

Gabriel A. Rabinovich

National Council of Scientific and Technical Research
Buenos Aires, AR

Hans-Georg Rammensee

University of Tübingen
Tübingen, DE

David H. Raulet

University of California, Berkeley
Berkeley, CA, US

Caetano Reis e Sousa

Cancer Research UK
London, UK

Nick Restifo

National Institute of Health
Bethesda, MA, US

Antoni Ribas

Jonsson Comprehensive Cancer Center
Los Angeles, CA, USA

Paola Ricciardi-Castagnoli

Singapore Immunology Network (SIgN)
Singapore, SG

Bruce Robinson

Perth, AU

Pedro Romero

Lausanne, CH

Alexander Rudensky

Sloan-Kettering Institute for Cancer Research
New York, NY USA

Shimon Sakaguchi

Institute for Frontier Medical Sciences at Kyoto University
Kyoto, Japan

Dolores J. Schendel

Münich, DE

Jeffrey Schlom

National Cancer Institute
Bethesda, MA, US

Hans Schreiber

Chicago, IL, US

Robert Schreiber

Washington University
St. Louis, MO, US

Gerold Schuler

University of Erlangen
Erlangen, DE

Ton Schumacher

Amsterdam, NL

Padmanee Sharma

The University of Texas, MD Anderson Cancer Center
Houston, TX USA

Hiroshi Shiku

Mie University Graduate School of Medicine
Mie, JP

Bruno Silva-Santos

Lisbon, PT

Mark J. Smyth

Melbourne, VIC, AU

Daniel E. Speiser

Ludwig Institute for Cancer Research at University of Lausanne
Lausanne, CH

Pramod K Srivastava

University of Connecticut School of Medicine
Farmington, CT, USA

Tadatsugu Taniguchi

Tokyo, JP

Eric Tartour

Hopital Européen Geoges Pompidou
Paris, FR

Alain Trautmann

Paris, FR

Giorgio Trinchieri

National Cancer Institute
Frederick, MD, US

Pablo Umana

Roche Glycart AG
Zurich, CH

Danila Valmori

University of Nantes
Nantes, FR

Benoît Van den Eynde

Ludwig Institute for Cancer Research
Brussels, BE
Web site

Pierre Van der Bruggen

Ludwig Institute for Cancer Research
Brussels, BE

Richard Vile

Rochester, MN, US

Eric Vivier

Centre d'Immunologie de Marseille-Luminy (CIML)
Marseille, FR

Hermann Wagner

Technical University Müchen
Munich, DE

Jeffrey Weber

Moffitt Cancer Center
Tampa, FL, USA

Theresa L Whiteside

Pittsburgh, PA, US

Ottmar D. Wiestler

German Cancer Research Center (DKFZ)
Heidelberg, DE

Jedd D. Wolchok

Memorial Sloan-Kettering Cancer Center
New York, NY USA

Cassian Yee

Fred Hutchinson Cancer Research Center
Seattle, WA

Weiping Zou

Ann Arbor, MI, US